반응식
Br[C:2]1[CH:3]=[C:4]([C:8]([N:10]=[S:11]([C:14]2[CH:15]=[C:16]([CH2:20][C:21]([O:23][CH3:24])=[O:22])[CH:17]=[CH:18][CH:19]=2)([CH3:13])=[O:12])=[O:9])[CH:5]=[N:6][CH:7]=1.[C:25]([C:27]1[CH:28]=[C:29]([NH:33][C:34]([C:36]2[N:40]([CH3:41])[N:39]=[C:38]([CH3:42])[CH:37]=2)=[O:35])[CH:30]=[CH:31][CH:32]=1)#[CH:26]>>[CH3:41][N:40]1[C:36]([C:34]([NH:33][C:29]2[CH:28]=[C:27]([C:25]#[C:26][C:2]3[CH:3]=[C:4]([C:8]([N:10]=[S:11]([C:14]4[CH:15]=[C:16]([CH2:20][C:21]([O:23][CH3:24])=[O:22])[CH:17]=[CH:18][CH:19]=4)([CH3:13])=[O:12])=[O:9])[CH:5]=[N:6][CH:7]=3)[CH:32]=[CH:31][CH:30]=2)=[O:35])=[CH:37][C:38]([CH3:42])=[N:39]1참가 물질
3
반응물 2
생성물 1
실험 절차
In a manner similar to that described in Example 460, methyl (3-{N-[(5-bromopyridin-3-yl)carbonyl]-S-methylsulfonimidoyl}phenyl)acetate (202 mg, 0.492 mmol) and N-(3-ethynylphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide (153 mg, 0.64 mmol), were converted to the title compound as a light yellow solid foam (275 mg, 98%).
출처 및 근거
- ORD 기록
- ord-0e0b99c3d076441f885ed4bac8624917
- 출처 데이터셋
- uspto-grants-2013_02
- 특허 번호
- US08383825B2
연결된 노트
불러오는 중…